Aardvark Therapeutics, Inc. (AARD)
Pharmaceutical Preparations
Latest Price
$6.60
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
3.99
P/B Ratio
1.66
Institutional Ownership
45.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Decheng Capital LLC | 3.92M | $14.0M | 17.96% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 1.30M | $4.0M | 5.94% | +6.4K | 2026-03-31 |
| Laurion Capital Management LP | 1.03M | $3.0M | 4.74% | +19.5K | 2026-03-31 |
| BlackRock, Inc. | 792.6K | $2.0M | 3.63% | +8.1K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 554.1K | $2.0M | 2.54% | -- | 2026-03-31 |
| TFG Asset Management GP Ltd | 316.6K | $1.0M | 1.45% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 309.4K | $1.0M | 1.42% | +11.6K | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300.0K | $1.0M | 1.38% | -50.0K | 2026-03-31 |
| STATE STREET CORP | 199.3K | -- | 0.91% | +41.1K | 2026-03-31 |
| UBS Group AG | 157.9K | -- | 0.72% | +131.1K | 2026-03-31 |